Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea

다국어 초록 (Multilingual Abstract)

Background: We investigated clinical course and risk factors for diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).
Methods: A total of 759 patients with T2DM without DR were included from January 2001 to December 2004. Retinopathy evaluation was performed at least annually by ophthalmologists. The severity of the DR was classified into five categories according to the International Clinical Diabetic Retinopathy Severity Scales.
Results: Of the 759 patients, 523 patients (68.9%) completed the follow-up evaluation. During the follow-up period, 235 patients (44.9%) developed DR, and 32 patients (13.6%) progressed to severe nonproliferative DR (NPDR) or proliferative DR (PDR). The mean duration of diabetes at the first diagnosis of mild NPDR, moderate NPDR, and severe NPDR or PDR were 14.8, 16.7, and 17.3 years, respectively. After adjusting multiple confounding factors, the significant risk factors for the incidence of DR risk in patients with T2DM were old age, longer duration of diabetes, higher mean glycosylated hemoglobin (HbA1c), and albuminuria.
Even in the patients who had been diagnosed with diabetes for longer than 10 years at baseline, a decrease in HbA1c led to a significant reduction in the risk of developing DR (hazard ratio, 0.73 per 1% HbA1c decrement; 95% confidence interval, 0.58 to 0.91; P=0.005).
Conclusion: This prospective cohort study demonstrates that glycemic control, diabetes duration, age, and albuminuria are important risk factors for the development of DR. More aggressive retinal screening for T2DM patients diagnosed with DR should be required in order to not miss rapid progression of DR.

참고문헌 (Reference)

1 Stratton IM, "UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6years from diagnosis" 44 : 156-163, 2001

2 Korean Diabetes Association, "Treatment guideline for diabetes" Gold’ Planning and Development 2015

3 UK Prospective Diabetes Study Group, "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38" 317 : 703-713, 1998

4 Lloyd CE, "The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study" 9 : 140-148, 1995

5 Tapp RJ, "The prevalence of and factors associated with diabetic retinopathy in the Australian population" 26 : 1731-1737, 2003

6 The Diabetes Control and Complications Trial Research Group, "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus" 329 : 977-986, 1993

7 Klein R, "The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study" 109 : 1225-1234, 2002

8 Klein R, "The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years" 102 : 527-532, 1984

9 Klein BE, "The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate" 98 : 1261-1265, 1991

10 American Diabetes Association, "Standards of medical care in diabetes: 2016" 39 (39): S1-S106, 2016

11 Kawasaki R, "Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study" 120 : 574-582, 2013

12 Luk AO, "Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes:prospective analysis of the Hong Kong Diabetes Registry" 29 : 384-390, 2013

13 Wilkinson CP, "Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales" 110 : 1677-1682, 2003

14 Grambsch PM, "Proportional hazards tests and diagnostics based on weighted residuals" 81 : 515-526, 1994

15 Colhoun HM, "Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial" 364 : 685-696, 2004

16 Wong TY, "Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study" 115 : 1869-1875, 2008

17 Gorst C, "Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis" 38 : 2354-2369, 2015

18 Gong Q, "Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study" 54 : 300-307, 2011

19 Klein BE, "Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration?" 128 : 652-654, 1999

20 ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2diabetes" 358 : 2560-2572, 2008

21 Gaede P, "Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study" 353 : 617-622, 1999

22 Younis N, "Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study:a cohort study" 361 : 195-200, 2003

23 Hirakawa Y, "Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial" 37 : 2359-2365, 2014

24 고승현, "Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011" 대한당뇨병학회 38 (38): 51-57, 2014

25 Penno G, "HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes:the Renal Insufficiency And Cardiovascular Events (RIACE)Italian multicenter study" 36 : 2301-2310, 2013

26 Park YM, "Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011)" 104 : 435-442, 2014

27 Yau JW, "Global prevalence and major risk factors of diabetic retinopathy" 35 : 556-564, 2012

28 Salinero-Fort MA, "Four-year incidence of diabetic retinopathy in a Spanish cohort:the MADIABETES study" 8 : e76417-, 2013

29 Lee R, "Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss" 2 : 17-, 2015

30 ACCORD Study Group, "Effects of medical therapies on retinopathy progression in type 2 diabetes" 363 : 233-244, 2010

31 Early Treatment Diabetic Retinopathy Study Research Group, "Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8" 98 (98): 757-765, 1991

32 Ismail-Beigi F, "Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial" 376 : 419-430, 2010

33 Keech AC, "Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial" 370 : 1687-1697, 2007

34 Wong TY, "Diabetic retinopathy in a multi-ethnic cohort in the United States" 141 : 446-455, 2006

35 Cheung N, "Diabetic retinopathy and systemic vascular complications" 27 : 161-176, 2008

36 Cheung N, "Diabetic retinopathy" 376 : 124-136, 2010

37 윤재승, "Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus" 대한당뇨병학회 37 (37): 262-269, 2013

38 Yun JS, "Cardiovascular autonomic dysfunction predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study" 37 : 235-241, 2014

39 윤재승, "Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes" 대한당뇨병학회 39 (39): 498-506, 2015

40 Rema M, "Association of serum lipids with diabetic retinopathy in urban South Indians: the Chennai Urban Rural Epidemiology Study (CURES)Eye Study 2" 23 : 1029-1036, 2006

41 Azad N, "Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)" 57 : 1124-1131, 2014

42 Funatsu H, "Association between serum lipoprotein (a) level and progression of non-proliferative diabetic retinopathy in type 2 diabetes" 87 : 501-505, 2009

43 Tung TH, "Assessing the natural course of diabetic retinopathy:a population-based study in Kinmen, Taiwan" 13 : 327-333, 2006

44 Bergerhoff K, "Aspirin in diabetic retinopathy:a systematic review" 31 : 779-793, 2002

45 Levey AS, "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group" 130 : 461-470, 1999